Extractables and Leachables (E&L) Testing

Introduction The structural integrity and long-term stability of biopharmaceutical drug products depend heavily on the chemical inertness of their primary […]

Introduction to Data Integrity in Extractables and Leachables Testing Digital data integrity in extractables and leachables testing refers to the

Introduction: Extractables and Leachables (E&L) Testing for Transdermal Patches is one of the most specialized and safety-critical analyses in modern

Identifying and addressing the root causes of failed Extractables and Leachables (E&L) studies has become a critical regulatory requirement for

Introduction: Patient safety begins long before a drug product reaches the clinic — it begins with the container that holds

Understanding the Regulatory Landscape of FDA Questions on E&L Studies The Food and Drug Administration (FDA) carefully evaluates extractables and

Introduction to the Advanced Landscape of Toxicological Qualification of Leachables The toxicological qualification of leachables is a critical process that

Introduction: Extractables and Leachables Testing for Ophthalmic Drug Products is not simply a regulatory checkbox — it is a critical

Introduction: Why ICP-MS Is Essential in E&L Investigations Whenever a drug product comes into contact with a container-closure system, manufacturing

Introduction: Why Leachables Monitoring Must Be Central to Your Stability Program Many sponsors still approach stability studies primarily as a